01:53 PM EDT, 03/23/2026 (MT Newswires) -- Health care stocks rose Monday afternoon with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each adding 0.2%.

The iShares Biotechnology ETF (IBB) rose 0.7%.

In corporate news, Insmed ( INSM ) shares jumped past 5% after it said a phase 3b trial of Arikayce as part of a multidrug regimen to treat patients with Mycobacterium avium complex lung infection who have not started antibiotics has met its primary and secondary endpoints.

Cencora ( COR ) agreed to buy EyeSouth Partners' retina business for $1.1 billion. Cencora ( COR ) shares were down 0.9%.

Apogee Therapeutics ( APGE ) shares surged 19% after 52-week maintenance data from part A of its phase 2 trial of zumilokibart in people with moderate-to-severe atopic dermatitis showed durable maintenance response and "deepening" response for lesional and itch endpoints.